Latest News
Tasmanian neurosceintist recognised for work in MS research
Dr Kaylene Young, a Tasmanian neuroscientist has this week been recognised for her work on brain stem cells. She said she was optimistic her research would one day offer hope for the treatment of both MS and Alzheimer’s disease.
Dr Young said common to both MS and Alzheimer’s was the loss...
The Aged care/NDIS interface
How do people with MS over the age of 65 have their disability needs met?
People with MS with a disability aged under 65 right across Australia will be able to apply for a National Disability Insurance Scheme (NDIS) package, once the NDIS is fully rolled out by 2019. There are already...
New look website and blogs!
We’ve spent some time stripping down the content of our website to make it more user friendly and we’re pleased to launch two new blogs on the NDIS and Federal Election 2016.
Are you new to the world of NDIS? Perhaps you know what it is but are still unclear about how it could help you?...
September announcement regarding full scheme rollout
As we mentioned in our introduction, we’re keeping our eyes and ears peeled for news as to how the NDIS pilot schemes are going. We were therefore pleased to read the latest quarterly report which included the following positive news:
- Nearly 20,000 people are now in the Scheme at...
Low vitamin-D genes linked to MS
We don't yet know what causes MS, but it's likely to be a complex link between genetic and environmental factors. So far, research has flagged up viruses, smoking and vitamin D as triggers that could affect your risk.
However recent research published in the journal ...
MS Research Australia awarded Charity of the Year
MS Research Australia has today been recognised as Charity of the Year in The Australian Charity Awards 2015.
Over the past 10 years MS Research Australia has greatly increased the level of funding for MS research; this has resulted in more research programs being carried out in the...
Double strength Copaxone available on the PBS
In March this year the Pharmaceutical Benefits Advisory Committee (PBAC), recommended a modified version of glatiramer acetate (Copaxone) for reimbursement on the Pharmaceutical Benefits Scheme. This medication for relapsing remitting MS became available on the PBS as of 1 August, 2015.
...
Decision to reduce NDIS prices for group support overturned
MS Australia welcomes the announcement from the National Disability Services (NDS) today on the National Disability Insurance Agency (NDIA) reversing its decision to reduce National Disability Insurance Scheme (NDIS) prices for group-based community, social and recreational activities.
...
Medikidz: Australian-first MS comic book for children launches
Global children’s healthcare education brand Medikidz - in collaboration with MS Australia and the Australian and New Zealand Association of Neurologists (ANZAN) – has launched an Australian-first educational comic designed to explain complex medical information about MS in a format that...
World MS Day: A thousand ways to raise hope for MS
Boats, bikes, mountains, weights and tutus — say what?
Can you guess what connects these disparate events and splendid people?
At this very moment Andrew Potter is aboard the Oceans of Hope, a 67 foot sailing boat circumnavigating the globe.
Last weekend Justine Martin from...
Catherine King welcomes Oceans of Hope
Over 23,000 people live with MS in Australia and more than two million worldwide.
Every year another 1,000 Australians are diagnosed with this cruel disease, most of them aged between 20 and 40, and despite great advances in treatment and care, it remains a disease without a cure.
...
Bill Shorten welcomes Oceans of Hope to Sydney
On behalf of Federal Labor, please accept my congratulations and best wishes for World MS Day 2015. The arrival of Oceans of Hope is a wonderful way to commemorate and celebrate this important day.
A global circumnavigation by a crew that includes people living with multiple sclerosis is...